# Influence of Testosterone Administration on Drug-Induced QT Interval Prolongation and Torsades de Pointes

> **NCT02513940** · PHASE4 · COMPLETED · sponsor: **Indiana University** · enrollment: 14 (actual)

## Conditions studied

- Long QT Syndrome

## Interventions

- **DRUG:** Testosterone
- **DRUG:** Progesterone
- **DRUG:** Placebo
- **DRUG:** Ibutilide

## Key facts

- **NCT ID:** NCT02513940
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05
- **Primary completion:** 2017-10-19
- **Final completion:** 2017-10-19
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2019-08-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02513940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02513940, "Influence of Testosterone Administration on Drug-Induced QT Interval Prolongation and Torsades de Pointes". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02513940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*